ArriVent BioPharma Reports Full Year 2023 Financial Results
March 28, 2024 16:05 ET
|
ArriVent BioPharma, Inc.
Company progresses the development of furmonertinib with a data readout planned for 2024Furmonertinib granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration Completed $201...
Drug Delivery Systems Market revenue to exceed USD 433 Billion by 2035, says Research Nester
March 18, 2024 05:00 ET
|
Research Nester
New York, March 18, 2024 (GLOBE NEWSWIRE) -- The global drug delivery systems market size is slated to expand at ~11% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 433...
Biotechnology Industry Insights: Comprehensive Report on Collaboration Deals from 2019-2024 Now Available
March 05, 2024 12:11 ET
|
Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. The biotechnology sector continues to...
Biotechnology Licensing Deals Analysis Reveals Key Trends and Major Agreements from 2019-2024
March 05, 2024 11:49 ET
|
Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Comprehensive Report Unveils In-Depth...
Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight
October 12, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight ...
Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys, Novartis, GlaxoSmithKline, Roche, BMS, TearSolutions, Incyte, Galapagos, Gilead Sciences
September 21, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys,...
Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out - AbbVie, Genmab, Merck, Xencor, Janssen, Roche, Biogen, Regeneron, Seagen, Takeda
September 19, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out - AbbVie, Genmab, Merck,...
Multiple Sclerosis Drugs Market Size to Surpass USD 31.90 Billion by 2030, exhibiting a CAGR of 5.9%
August 21, 2023 05:31 ET
|
Fortune Business Insights
Pune, India, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The multiple sclerosis drugs market was USD 22.32 billion in 2022 and is anticipated to expand from USD 21.33 billion in 2023 to USD 31.90 billion in...
InnoCare and ArriVent Announce Clinical Development Collaboration
July 13, 2023 20:30 ET
|
ArriVent Biopharma
BEIJING and NEWTOWN SQUARE, Pa., July 13, 2023 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune...
B-Cell Lymphoma Clinical Trial Pipeline Insights: DelveInsight Evaluates a Robust Pipeline as 160+ Influential Pharma Players to Set Foot in the Domain
May 31, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 31, 2023 (GLOBE NEWSWIRE) -- B-Cell Lymphoma Clinical Trial Pipeline Insights: DelveInsight Evaluates a Robust Pipeline as 160+ Influential Pharma Players to Set Foot in the...